Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DIPRIVAN | Fresenius Kabi | N-019627 RX | 1996-06-11 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
diprivan | New Drug Application | 2025-02-20 |
propofol | ANDA | 2025-01-20 |
propofol 1% | unapproved drug other | 2023-12-27 |
propofol injectable emulsion | ANDA | 2022-09-30 |
propofol lipuro | unapproved drug other | 2021-12-20 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
pain | EFO_0003843 | D010146 | R52 |
delirium | — | D003693 | R41.0 |
psychomotor agitation | — | D011595 | — |
status epilepticus | EFO_0008526 | D013226 | G41 |
Code | Description |
---|---|
J2704 | Injection, propofol, 10 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
General anesthesia | D000768 | — | — | — | — | 1 | — | — | 1 |
Elective surgical procedures | D017558 | — | — | — | — | 1 | — | — | 1 |
Critical illness | D016638 | — | — | — | — | 1 | — | — | 1 |
Nutrition therapy | D044623 | — | — | — | — | 1 | — | — | 1 |
Drug common name | Propofol |
INN | propofol |
Description | Propofol is a phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group. It has a role as an intravenous anaesthetic, a sedative, a radical scavenger, an antiemetic and an anticonvulsant. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC(C)c1cccc(C(C)C)c1O |
PDB | — |
CAS-ID | 2078-54-8 |
RxCUI | — |
ChEMBL ID | CHEMBL526 |
ChEBI ID | 44915 |
PubChem CID | 4943 |
DrugBank | DB00818 |
UNII ID | YI7VU623SF (ChemIDplus, GSRS) |